Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2025-12-29 @ 2:22 PM
Study NCT ID:
NCT01292603
Status:
COMPLETED
Last Update Posted:
2018-12-19
First Post:
2011-02-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-04-18
Start Date Type:
ACTUAL
Primary Completion Date:
2014-05-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-11-17
Completion Date Type:
ACTUAL
First Submit Date:
2011-02-08
First Submit QC Date:
None
Study First Post Date:
2011-02-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-09-23
Results First Submit QC Date:
None
Results First Post Date:
2015-12-15
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-17
Last Update Post Date:
2018-12-19
Last Update Post Date Type:
ACTUAL